RIO DE JANEIRO (Reuters) – Brazil’s Fiocruz biomedical institute said on Tuesday it would not be able to deliver finished doses of a coronavirus vaccine developed by AstraZeneca until March due to a delayed shipment of active ingredients from China.
Initially, Fiocruz had estimated it would be able to deliver 1 million AstraZeneca doses by mid-February.
(Reporting by Pedro Fonseca)
